India’s exporters are poised for a competitive edge in Europe, thanks to the freshly inked FTA with the EU. Industry experts predict it will neutralize advantages held by rivals such as Vietnam, Bangladesh, Thailand, Malaysia, and Sri Lanka, unlocking billions in trade potential.
Polymedicure CEO Himmashu Vaidh called the agreement transformative. ‘Access to 27 markets at once is a strategic masterstroke,’ he asserted. Reduced duties will amplify export scales, while technology inflows promise to modernize Indian industries.
The deal’s reciprocity shines through: EU firms eye India’s dynamic economy for expansion. Vaidh forecasts heightened investments and manufacturing revival, creating a virtuous cycle of growth. This isn’t just trade—it’s a catalyst for industrial renaissance.
From the medtech perspective, EPCMD Chairman R.S. Konwar is optimistic yet pragmatic. ‘Tariff elimination on devices is excellent, but non-tariff barriers must go,’ he warned. Only then can Indian innovators fully capture Europe’s healthcare demands.
Echoing this, Prime Minister Modi portrayed the FTA as a shared prosperity roadmap. It prioritizes farmers and SMEs with easier market entry, ignites manufacturing hubs, and fortifies services collaboration. India’s trade narrative evolves from challenger to champion.